BSE Live
Nov 03, 09:00Prev. Close
390.55
Open Price
0.00
Bid Price (Qty.)
388.35 (13)
Offer Price (Qty.)
394.95 (50)
NSE Live
Oct 31, 15:40Prev. Close
384.30
Open Price
387.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
388.35 (30)
| Key Financial Ratios of Kilitch Drugs (India) (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.89 | 10.06 | 4.68 | -0.03 | -1.55 | |
| Diluted EPS (Rs.) | 2.89 | 10.06 | 4.40 | -0.03 | -1.55 | |
| Cash EPS (Rs.) | 3.63 | 10.40 | 5.38 | 0.97 | -0.33 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 98.25 | 98.39 | 95.54 | 89.95 | 89.12 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 98.25 | 98.39 | 95.54 | 89.95 | 89.12 | |
| Dividend / Share(Rs.) | 0.00 | 0.50 | 0.50 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 39.37 | 62.79 | 36.75 | 21.27 | 15.89 | |
| PBDIT/Share (Rs.) | 4.59 | 13.75 | 6.08 | 0.65 | -0.66 | |
| PBIT/Share (Rs.) | 3.85 | 12.96 | 5.21 | -0.35 | -1.88 | |
| PBT/Share (Rs.) | 3.38 | 12.72 | 5.21 | -0.35 | -1.88 | |
| Net Profit/Share (Rs.) | 2.89 | 9.62 | 4.51 | -0.03 | -1.55 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.66 | 21.89 | 16.54 | 3.05 | -4.17 | |
| PBIT Margin (%) | 9.77 | 20.64 | 14.18 | -1.63 | -11.84 | |
| PBT Margin (%) | 8.59 | 20.25 | 14.18 | -1.63 | -11.84 | |
| Net Profit Margin (%) | 7.33 | 15.31 | 12.27 | -0.12 | -9.76 | |
| Return on Networth / Equity (%) | 2.93 | 9.77 | 4.72 | -0.03 | -1.74 | |
| Return on Capital Employed (%) | 3.90 | 13.13 | 5.45 | -0.38 | -1.74 | |
| Return on Assets (%) | 2.55 | 8.58 | 4.26 | -0.02 | -1.63 | |
| Total Debt/Equity (X) | 0.08 | 0.06 | 0.01 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 34.90 | 56.04 | 34.71 | 21.65 | 16.72 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.54 | 3.13 | 4.37 | 4.40 | 5.99 | |
| Quick Ratio (X) | 2.29 | 2.90 | 4.17 | 4.16 | 5.65 | |
| Inventory Turnover Ratio (X) | 10.94 | 20.45 | 18.04 | 10.84 | 8.02 | |
| Dividend Payout Ratio (NP) (%) | 20.87 | 6.26 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 16.58 | 5.79 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 79.13 | 93.74 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 83.42 | 94.21 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 135.19 | 308.86 | 106.05 | 58.89 | 43.88 | |
| EV/Net Operating Revenue (X) | 2.22 | 3.20 | 2.10 | 2.09 | 2.09 | |
| EV/EBITDA (X) | 19.06 | 14.63 | 12.70 | 68.58 | -50.03 | |
| MarketCap/Net Operating Revenue (X) | 2.06 | 3.15 | 2.16 | 2.15 | 2.20 | |
| Retention Ratios (%) | 79.12 | 93.73 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.83 | 2.01 | 0.83 | 0.51 | 0.39 | |
| Price/Net Operating Revenue | 2.06 | 3.15 | 2.16 | 2.15 | 2.20 | |
| Earnings Yield | 0.04 | 0.05 | 0.06 | 0.00 | -0.04 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y